[Federal Register Volume 63, Number 119 (Monday, June 22, 1998)]
[Notices]
[Page 33964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-16523]


-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Advisory Committee for Biological Sciences; Committee of 
Visitors, Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting:

    Name: Advisory Committee for Biological Sciences: Committee of 
Visitors (1110).
    Date and Time: July 22-24, 1998; 8:30 A.M. to 5:00 P.M. each 
day.
    Place: National Science Foundation, Room 330, 4201 Wilson 
Boulevard, Arlington, Virginia 22230.
    Contact Person: Dr. Maryanna Henkart, Division Director for 
Molecular and Cellular Biosciences, National Science Foundation, 
4201 Wilson Boulevard, Arlington, Virginia, (703) 306-1440.
    Purpose of Meeting: To carry out Committee of Visitors (COV) 
review, including program evaluation, GPRA assessments, and access 
to privileged materials.
    Type of Meeting: Part open (see agenda below):

Agenda

    Closed: July 22 (11:00 a.m.-5:00 p.m.); July 23 (8:30 a.m.-9:00 
a.m., and 2:00 p.m.-5:00 p.m.); and July 24 (8:30 a.m.-12:00 a.m.)--
To review the merit review processes covering funding decisions made 
during the immediately preceding three fiscal years of programs in 
the Division of Molecular and Cellular Biosciences.
    Open: July 22 (8:30 a.m.-11:00 a.m.); July 23 (9:00 a.m.-2:00 
p.m.), and July 24 (1:00 p.m.-4:00 p.m.)--To assess the results of 
NSF program investments in the Molecular and Cellular Biosciences 
Division. This shall involve a discussion and review of results 
focused on NSF and grantee outputs and related outcomes achieved or 
realized during the preceding three fiscal years. These results may 
be based on NSF grants or other investments made in earlier years.
    Reason for Closing: During the closed session, the Committee 
will be reviewing proposal actions that will include privileged 
intellectual property and personal information that could harm 
individuals if they were disclosed. If discussions were open to the 
public, these matters that are exempt under 5 U.S.C. 552b(c) (4) and 
(6) of the Government in the Sunshine Act would be improperly 
disclosed.

    Dated: June 17, 1998.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 98-16523 Filed 6-19-98; 8:45 am]
BILLING CODE 7555-01-M